Comparison between Entecavir and Lamivudine as Hepatitis B Reactivation Prophylaxis in Cancer Patient with Chemotherapy

Abstract

Aim: To compare between entecavir and lamivudine as hepatitis B reactivation prophylaxis in cancer patient with chemotherapyMethod could evoke its resistance lead to a question about how effective entecavir as a drug of choice in Indonesia for HBV reactivation prophylaxis in chemotherapy patients. This is the reason why this topic were discussed in this evidence-based case report.